Acelyrin Inc (NASDAQ: SLRN) on Friday, soared 3.40% from the previous trading day, before settling in for the closing price of $2.06. Within the past 52 weeks, SLRN’s price has moved between $1.85 and $8.89.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 53.73%. With a float of $72.57 million, this company’s outstanding shares have now reached $99.94 million.
The extent of productivity of a business whose workforce counts for 130 workers is very important to gauge. In terms of profitability, gross margin is -31.93%, operating margin of -202203.61%, and the pretax margin is -159280.12%.
Acelyrin Inc (SLRN) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Acelyrin Inc is 27.71%, while institutional ownership is 70.39%. The most recent insider transaction that took place on Jul 17 ’24, was worth 7. In this transaction Director of this company sold 1 shares at a rate of $6.86, taking the stock ownership to the 2,999 shares. Before that another transaction happened on Apr 01 ’24, when Company’s Chief Executive Officer sold 9,961 for $6.63, making the entire transaction worth $66,024. This insider now owns 1,577,374 shares in total.
Acelyrin Inc (SLRN) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.65 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 53.73% per share during the next fiscal year.
Acelyrin Inc (NASDAQ: SLRN) Trading Performance Indicators
Acelyrin Inc (SLRN) is currently performing well based on its current performance indicators. A quick ratio of 7.15 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.68, a number that is poised to hit -0.82 in the next quarter and is forecasted to reach -2.18 in one year’s time.
Technical Analysis of Acelyrin Inc (SLRN)
The latest stats from [Acelyrin Inc, SLRN] show that its last 5-days average volume of 3.63 million was superior to 2.48 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 50.19%. Additionally, its Average True Range was 0.18.
During the past 100 days, Acelyrin Inc’s (SLRN) raw stochastic average was set at 6.10%, which indicates a significant decrease from 65.52% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 62.87% in the past 14 days, which was lower than the 104.95% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.72, while its 200-day Moving Average is $4.43. Now, the first resistance to watch is $2.16. This is followed by the second major resistance level at $2.20. The third major resistance level sits at $2.25. If the price goes on to break the first support level at $2.07, it is likely to go to the next support level at $2.02. The third support level lies at $1.98 if the price breaches the second support level.
Acelyrin Inc (NASDAQ: SLRN) Key Stats
Market capitalization of the company is 213.70 million based on 100,326K outstanding shares. Right now, sales total 0 K and income totals -381,640 K. The company made 0 K in profit during its latest quarter, and -48,550 K in sales during its previous quarter.
